PCSK9 and atherosclerosis: Despite the emerging role of PCSK9 in ASCVD [28], there is lack of robust clinical data investigating the interplay of PCSK9 with markers of inflammation, oxidative stress, and endothelial dysfunction in high-risk patients such as CKD patients.